This is a potentially transformative piece of news.
If the stock were to become treated like a drug development company because of the fact that its product may WORK LIKE A PHARMACEUTICAL, then it could EASILY obtain a $100-$200 million equity market cap. That would be a price range of $20-$40 per share.
You got all the clue calling this a $20-40 stock. If in the next few minutes, this dips back to high $3s, can you please explain to me how a $20-40 stock cant even stay in low $4s and has to go back to $3s
You do that while I count my big profits SHORTING THIS in mid $4s
$20 stock. what a joke. All momentum and volume will be gone by tomorrow. back to high $3s is the best case scenario for you longs
Do you see anybody buying this now???? plain and simply question. price aint going up, so many sellers now